F-41 Sorafenib for hepatocellular carcinoma (HCC) in patients with established cirrhosis: impact of the type of recruiting unit and predictors of survival

✍ Scribed by Inghilesi, A.; Antonuzzo, L.; Gallori, D.; Forte, P.; Tomcikova, D.; Arena, U.; Colagrande, S.; Pradella, S.; Fani, B.; Gianni, E.; Boni, L.; Laffi, G.; Di Costanzo, F.; Marra, F.

• Book ID: 122458612
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 57 KB
• Volume: 45
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/S1590-8658(13)60133-4